SOPHiA GENETICS SA (SOPH) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY24 Revenue Guidance

Go back to SOPHiA GENETICS SA (SOPH) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY24 Revenue Guidance

SOPHiA GENETICS Reports Second Quarter 2024 Results

August 6, 2024 6:45 AM EDT

Strength in U.S. Growth Offset by Challenges in BioPharma and EMEA; Strong Cost Management Buffers Loss

BOSTON and ROLLE, Switzerland, Aug. 6, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the second quarter ended June 30, 2024.

... More